A randomized controlled trial of a bicarbonate- and a bicarbonate/lactate-containing dialysis solution in CAPD

Peritoneal Dialysis International

Volumn 17, Issue 1, 1997, Pages 48-51

  Coles, Gerald A ^a   Gokal, Ram ^b   Ogg, Chisholm ^c   Jani, Fiona ^c   O'Donoghue, Donal T ^b   Cancarinu, Giovanni C ^d   Maiorca, Rosario ^d   Tranaeus, Anders ^e   Faict, Dirk ^e   De Vos, Catherine ^e  

^a Cardiff Royal Infirmary   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d Spedale Civili Brescia   (Italy)

^e Cardiff Royal Infirmary ^*

Author keywords

Bicarbonate; Dialysis solutions; Lactate

Indexed keywords

BICARBONATE; LACTIC ACID; PERITONEAL DIALYSIS FLUID;

ADULT; AGED; ARTICLE; BICARBONATE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTINUOUS AMBULATORY PERITONEAL DIALYSIS; CONTROLLED CLINICAL TRIAL; HUMAN; KIDNEY TUBULE ACIDOSIS; LACTATE BLOOD LEVEL; MULTICENTER STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

EID: 9844256456     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686089701700111     Document Type: Article

References (23)

1. Duwe AK, Vas SI, Weatherhead JD. Effects of the composition of peritoneal dialysis fluid on chemiluminescence, phagocytosis and bactericidal activity in vitro. Infect Immun 1981; 33:130-5.
2. Topley N, Alobaidi HMM, Davies M, Coles GA, Williams JD, Lloyd D. The effect of dialysate on peritoneal phagocyte oxidative metabolism. Kidney Int 1988; 34:404-11.
3. Ing BL, Gupta DK, Nowab SM, Zhou FQ, Rahman MA, Daugirdas JT. Suppression of neutrophil superoxide production by conventional peritoneal dialysis solution. Int J Artif Organs 1988; 11:351-4.
4. 4 and tumor necrosis factor release from leukocytes: effect of peritoneal dialysate. Nephron 1991; 58:276-82.
5. Van Bronswijk H, Verbrugh HR, Bos HJ, et al. Cytotoxic effects of commercial continuous ambulatory peritoneal dialysis (CAPD) fluids and of bacterial exoproducts on human mesothelial cells in vitro. Perit Dial Int 1989; 9:197-202.
6. Witowski J, Topley N, Jörres A, Liberek T, Coles GA, Williams JD. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 1994; 47:282-93.
7. Manahan FJ, Ing BL, Chan JC, Zhou F-Q, Rahman MA, Daugirdas JT. Effects of bicarbonate-containing versus lactate-containing peritoneal dialysis solutions on superoxide production by human neutrophils. Artif Organs 1989; 13:495-7.
8. Fischer H-P, Shenk U, Kiefer T, et al. In vitro effects of bicarbonate versus lactate-buffered continuous ambulatory peritoneal dialysis fluids on peritoneal macrophage function. Amer J Kid Dis 1995; 26:924-33.
9. Pedersen FB. Lactate- versus bicarbonate-based peritoneal dialysis solutions. Perit Dial Int 1995; 15(Suppl 7):S47-51.
10. Veech RL. The untoward effects of the anions of dialysis fluids. Kidney Int 1988; 34:587-92.
11. Romagnoni M, Beccari M, Faiolo S,et al. Abdominal pain with infusion of the peritoneal dialysis solutions relieved by alkalinization. Perit Dial Bull 1984; 4:188-9.
12. Bunchnian TE, Ballal SH. Treatment of inflow pain by pH adjustment of dialysate in peritoneal dialysis.Perit Dial Int 1991; 11:179-80.
13. Feriani M, Biasoli S, Borin D, et al. Bicarbonate solutions for peritoneal dialysis: a reality. Int J Artif Organs 1985; 8:57-8.
14. Schambye HT, Pedersen FB, Wang P. Bicarbonate is not the ultimate answer to the biocompatibility problems of CAPD solutions: a cytotoxicity test of CAPD solutions and effluents. Adv Perit Dial 1992; 8:42-6.
15. Schambye HT, Pedersen FB, Christensen HK, Berthelsen H, Wang P. The cytotoxicity of continuous ambulatory peritoneal dialysis solutions with different bicarbonate/lactate ratios. Perit Dial Int 1993; 13 Suppl 2:S116-8.
16. De Fijter CWH, Verbrugh HA, Peters EDJ, et al. In vivo exposure to the currently available peritoneal dialysis fluids decreases the function of peritoneal macrophages in CAPD. Clin Nephrol 1993; 39:75-80.
17. Yatzidis H. A new stable bicarbonate dialysis solution for peritoneal dialysis: preliminary report. Perit Dial Int 1991; 11:224-7.
18. Yamamoto T, Sakakura T, Yamakawa M, et al. Clinical effect of long-term use of neutralized dialysate for continuous ambulatory peritoneal dialysis. Nephron 1992; 60: 324-9.
19. Feriani M, Dissegna D, La Greca G, Passlick-Deetjen J. Short-term clinical study with bicarbonate-containing peritoneal dialysis solution. Perit Dial Int 1993; 13:296-30.
20. Holmes CJ, Topley N, Kaur D,et al. A biocompatibility comparison of bicarbonate- versus bicarbonate/lactate-based solutions for peritoneal dialysis (PD). J Am Soc Nephrol 1994; 5: 453.
21. Feriani M, Passlick-Deetjen J, Brown C, et al. An open controlled randomized clinical trial with bicarbonate CAPD solutions: interim results. J Am Soc Nephrol 1994; 5:414.
22. Yatzidis H. Enhanced ultrafiltration in rabbits with bicarbonate glycylglycine peritoneal dialysis solution. Perit Dial Int 1993; 13:302-6.
23. Coles GA. Are solutions presently used bioincompatible? Perit Dial Int 1995; Suppl 7:S109-14.